Johanna Holldack

F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland.

Oslo Cancer Cluster NCE is an oncology research firm that specializes in developing cancer diagnostics and medicines. The private company is based in Oslo, Norway.

The Atlantic Urology Clinics, LLC (AUC) team is comprised of twelve Board Certified Urologists, one Pathologist and two Physician Assistants dedicated to providing cutting edge urologic care. Educated and trained at some of the top medical schools and teaching hospitals in the nation, their Urologists combine proficiency with exceptional skill in advanced surgical techniques. AUC’s leading edge care and state-of-the-art technology includes on-site radiology, laboratory & pathology services, two ambulatory surgical centers and a clinical research branch called Carolina Urologic Research Center. They have eleven Urologic Centers of Excellence to conveniently serve their patients in and around Horry, Georgetown, Brunswick and Marion counties. AUC’s leading edge care and state-of-the-art technology includes on-site radiology, laboratory & pathology services, two ambulatory surgical centers and a clinical research branch called Carolina Urologic Research Center. They have eleven Urologic Centers of Excellence to conveniently serve their patients in and around Horry, Georgetown, Brunswick and Marion counties.

Radiumhospitalets Forskningsstiftelse invests in companies from Nordic research institutions. It is a pre-seed investor and project developer focused on cancer. It strengthens cancer research at Rikshospitalet University Hospital, including The Norwegian Radium Hospital. It provides Oslo Cancer Cluster with the necessary infrastructure and management team, as well. The company was founded in 1986 and is headquartered in Lysaker, Norway.

GE Healthcare AS markets contrast agent for x-ray, ultrasound, Magnetic Resonance Imaging, and radiopharmaceuticals for clinicians to predict, diagnose, inform, and treat diseases. The company was founded on September 07, 1981 and it is headquartered in Oslo, Norway.

Part of Ernst & Young Global Ltd., Ernst & Young AS is a Norwegian company that provides accounting services. The private company is based in Oslo, Norway. The CEO of the company is Christin Erichsen Bøsterud.

Shire Pharmaceuticals, Inc. manufactures pharmaceutical products. The company offers solutions for attention deficit & hyperactivity disorder, human genetic therapies, gastrointestinal, and renal diseases. The company was founded in 1986 and is headquartered in Wayne, PA

The Association for Accessible Medicines is an organization that aims to make generic and biosimilar medicines more accessible to those who need them. The organization is based in Arlington, VA. The non-profit company believes that increasing competition is the key to tackling the high cost of prescription drugs, rather than shifting costs among healthcare stakeholders. In 2022, generic and biosimilar prescription medicines saved $408 billion for the healthcare system overall, with more than $2.90 trillion saved over the past 10 years. The company was founded by Milan Puskar, Robert R. Grusky. David Gaugh has been the CEO of the company since 2012.

Xellia Pharmaceuticals AS develops, manufactures, and supplies pharmaceutical drugs. The firm engages in the filed of biotechnology, synthetic organic chemistry development, and analytical development. The company was founded in 1946 and is headquartered in Oslo, Norway.

Formuesforvaltning AS provides wealth management services to the private individuals, foundations, entrepreneurs, families, institutions and regulated customers. Its services include wealth planning, portfolio management and reporting, business management, art and philanthropy and legal services. The company was founded by Ole Jacob Sunde in 2000 and and is headquartered in Oslo, Norway.

Nextera AS provides drug research for therapeutic interventions for autoimmune diseases, chronic infections, and cancer. It offers platform for protein engineering and evolution, such as life sciences, drug discovery, and lead optimization fields. The firm’s core competence lies within protein engineering and evolution utilizing its technology to epitope discovery and epitope validation, as well as lead-candidate generation and validation in-vitro. The company was founded by Geir Åge Løset and Inger Sandlie in 2009 and is headquartered in Oslo, Norway.

Novartis Norge AS develops, markets, and trades pharmaceuticals. It offers ophthalmic and generic products. The company is headquartered in Oslo, Norway.

Boehringer Ingelheim (BIVF) is the venture capital arm of Boehringer Ingelheim International GmbH, itself a subsidiary of C.H. Boehringer Sohn AG & Co. KG. The firm was founded in 2010 and is headquartered in Ingelheim, Germany. It also has two US offices located in Fremont, California, and Cambridge, Massachusetts.

STAT-Dx Life SL focuses on the development, manufacturing and commercialization of diagnostic solutions for fast and accurate diagnostic results of infectious diseases and critical care. It solution offers DiagCORE Cartridge, for sample and analyzation of cell material, nucleic acid purification, amplification and hybridization process. The company was founded by Jordi Cabrrera Fabra and Rafael Bru Gibert in 2010 and is headquartered in Barcelona, Spain.

Hookipa Biotech AG develops new generation prophylactic and therapeutic vaccines. The firm’s Vaxwave technology is a novel immunotherapy platform using a replication-defective viral vector for the prevention and treatment of cancer and infectious diseases. The company was founded by Lukas Flatz, Andreas Bergthaler, Rolf M. Zinkernagel and Daniel Pinschewer in July 2011 and is headquartered in Vienna, Austria.

Eyevensys SAS develops non-viral gene therapy process for the treatment of ocular illnesses. The firm's process enables prolonged production of all therapeutic proteins through electrotransfer. Its product, the single-used device is designed for treating ocular illnesses. The company was founded by Francine Behar-Cohen on December 8, 2008 and is headquartered in Paris, France.

Acousia Therapeutics GmbH identifies small molecules for treatment of hearing loss. The firm develops drugs for local application, which will protect hearing function or restore hearing in patients who have lost their hearing ability due to various reasons. It also develops small molecule compounds that trigger regeneration of sensory hair cells and therefore allow casual treatment of sensorineural hearing loss in patients who already lost their hair cells years ago. The company was founded by Hubert Löwenheim and Karl-Heinz Wiesmüller in 2012 and is headquartered in Tübingen, Germany.

eTheRNA immunotherapies NV develops novel immunotherapies to overcome cancers and infectious diseases. The company was founded by Carlo Heirman, Kris Thielemans and Sonja van Meirvenne in January 21, 2013 and is headquartered in Niel, Belgium.

Cardior Pharmaceuticals GmbH develops, manufactures and wholesales drugs. It focuses on the discovery, development and clinical validation of noncoding RNA therapeutics targeting microRNAs as medicines for patients with various forms of heart failure. The company was founded by Sandor Batkai, Claudia Ulbrich, and Thomas Thum on July 21, 2016 and is headquartered in Hannover, Germany.

Zelluna Immunotherapy AS engages in research and development on biotechnology. The company is headquartered in Oslo, Norway.

Colosseum Smile Group AB operates dental care clinics. The private company is based in Stockholm, Sweden.

Part of Storebrand ASA, Kron AS is a Norwegian company that provides investment advice. The private company is based in Oslo, Norway. The company was founded in 2017 by Joar Hagatun. Emma Tryti has been the CEO of the company since 2020. Kron was acquired by Storebrand ASA on January 03, 2023 for $40.18 million.

Serendipity Partners Management AS (Serendipity Partners) is a private equity/venture capital firm founded in 2015 by Michael Bodd. The firm is headquartered in Oslo, Norway.

Aelin Therapeutics NV develops drugs for antibiotics and first-in-class therapeutics. The company is based in Leuven, Belgium. The Belgian company was founded in 2017. The CEO is Els Beirnaert.

T3 Pharmaceuticals AG provides medicines and treatment for cancer patient. The company was founded in May 2015 by Simon J. Ittig, Christoph A. Kasper, Marlise Amstutz and Helmut H. Kessmann and is headquartered in Basel, Switzerland.

Ownersroom is a Norwegian company that provides tools for efficient and professional board and investor management. The private company is based in Oslo, Norway. The company aims to unlock private capital by streamlining investor processes. The company's services include digital signing, document room, updates, and more.

Rinri Therapeutics Ltd. operates as a biotechnology company developing a novel cell-based therapy to restore hearing. The company was founded in 2018 and is headquartered in Sheffield, the United Kingdom.

First Seed is a regional venture capital fund that invests in early-stage companies located in the region of Hedmark in Norway. It initially invests in 8-15 startups with significant growth potential and uses the returns from those investments for investing in other companies. The fund has no industry limitations and always co-invests together with other investors.

Innovation Norway (California) is a private company based in San Francisco, CA. The company is the Norwegian government's and the county municipalities' primary tool for innovation and development of Norwegian enterprises and industry. The company assists companies in developing their competitive advantage and enhancing innovation. Innovation Norway combines local industry knowledge and international networks with the business ideas and motivation of entrepreneurs to create a foundation for new successful businesses.

Part of Artbio, Inc., Artbio AS is a clinical-stage radiopharmaceutical biotechnology business that works to create a new class of alpha radio ligand medicines. The private company is based in Oslo, Norway. The Norwegian company was founded in 2018. The CEO is Emanuele Ostuni.

Oslo Stock Exchange operates as a Stock exchange. The company is headquartered in Oslo, Norway.